Pathogenesis of Bacterial Uveitis.

Adaptive immunity Lyme disease bartonellosis borreliosis brucellosis innate immunity pathogenesis syphilis tuberculosis uveitis

Journal

Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 7 9 2023
pubmed: 10 1 2023
entrez: 9 1 2023
Statut: ppublish

Résumé

To describe the pathogenesis and the general immune mechanisms of the most frequent causes of bacterial uveitis. Narrative review. Both extra- and intracellular bacteria can induce uveitis, whereas intracellular bacteria are generally transported into the inner eye via cells of the innate immune system, mainly macrophages. Systemic adaptive immunity is usually induced before the bacteria are localized to the inner eye, and once T and B cells have detected the pathogens behind the blood-eye barriers they elicit an acute and/or chronic inflammatory response deteriorating visual acuity that can severely affect the non-regenerating, intraocular tissues. An understanding of pathogenic mechanisms, and its correlation with clinical and imaging features, can facilitate early recognition of microbial factors and institution of appropriate therapy.

Identifiants

pubmed: 36622856
doi: 10.1080/09273948.2022.2155842
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1396-1404

Auteurs

Gerhild Wildner (G)

Department of Ophthalmology, University Hospital, LMU, Munich, Germany.

Reema Bansal (R)

Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Nikitha Ayyadurai (N)

Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Stephan Thurau (S)

Department of Ophthalmology, University Hospital, LMU, Munich, Germany.

Soumyava Basu (S)

Prof Brien Holden Eye Research Center, LV Prasad Eye Institute, Hyderabad, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH